GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Bcl2l11 | increases activity | ISO | BCL2L11 (Homo sapiens) | 6480464 | CTD | Bortezomib results in increased activity of BCL2L11 protein | PMID:16446371 | Bcl2l11 | increases expression | ISO | BCL2L11 (Homo sapiens) | 6480464 | CTD | Bortezomib results in increased expression of BCL2L11 protein | PMID:16024631 PMID:17326159 PMID:18566236 | Bcl2l11 | increases response to substance | ISO | BCL2L11 (Homo sapiens) | 6480464 | CTD | BCL2L11 results in increased susceptibility to Bortezomib | PMID:18566236 | Bcl2l11 | multiple interactions | ISO | BCL2L11 (Homo sapiens) | 6480464 | CTD | [Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein; Acetylcysteine inhibits the reaction [[Bortezomib co-treated with romidepsin] results in increased expression of BCL2L11 protein]; Bortezomib inhibits the reaction [Arsenic Trioxide results in increased degradation of BCL2L11 protein] | PMID:15173094 PMID:36509116 | |
Go Back to source page | Continue to Ontology report |